CREB1 and Cognitive impairment: In conclusion, we demonstrated that the H3R antagonist thioperamide improved cognitive impairment in APP/PS1 mice via modulation of the CREB‐mediated autophagic and lysosomal pathway, which contributed to Aβ clearance (Figure 9).